NIGMS - National Institute of General Medical Sciences
Project Summary Alternative splicing (AS) is a widespread phenomenon in human genes that significantly diversifies the types of proteins and RNAs produced. This process plays an essential role in defining cellular differentiation and identity3,4. Moreover, problems in alternative splicing have been directly linked to a range of human diseases such as muscular dystrophies, neurodegenerative conditions, and cancers. The typical human gene has about eight introns, which are processed by spliceosomal subunits that recognize sequences near splice sites (SSs) and branchpoints. During the splicing process, AS arises as the result of kinetic competition between multiple possible splicing outcomes that is influenced by cis-elements and trans-acting factors. Additionally, AS is influenced by chromatin and transcription rates, as splicing is coupled with gene transcription. The splicing process and its regulation are highly transient. Spliceosomal assembly is initiated by U1 snRNP binding to the 5’ SS and the branch point located upstream of the 3’SS is recognized by the U2 snRNP. Subunits of both U1 and U2 associate with Pol II co-transcriptionally prior to recognizing their respective cis-elements. Additionally, regulatory factors that aid in splice site recognition and control splicing outcomes bind to specific sequences in nascent RNA. Since these cis-elements are usually located within introns, their influence is temporary and lasts only until the introns are removed. Thus, to understand AS requires quantitative in vivo analyses of the dynamics of intron excision within the context of the native genomic context. Our group has pioneered tools that obtain direct, high-resolution, and quantitative views into the endogenous splicing process, both during and after transcription. These methods have revealed that splicing itself occurs far after RNA synthesis14 and that the order of intron excision is largely fixed across cell types and controlled heavily by cis-elements in the nascent RNA13. Here we propose to apply these tools to determine how trans-acting factors affect the relationship between transcription and splicing and how cis-elements in nascent RNA impact splicing dynamics and outcome. We will examine how regulators of splicing and transcription manage the intricate relationship between these two processes. To examine how cis-elements control splicing order, we will investigate how natural variation of the pre-mRNA sequence influence its processing. Additionally, we will use our unique RNA flow technique15 to quantitatively track RNA molecules throughout their life cycle, from synthesis to degradation, giving us insights into how these factors affect the RNA's ultimate fate. In specific aim 1, we will investigate mechanisms of factors connecting splicing to transcription. In specific aim 2, we will study the role of cis-elements in determining splicing order. Overall, our multi-faceted approach aims to provide a comprehensive understanding of the mechanisms that regulate RNA processing, offering critical insights that could inform future research and therapeutic strategies.
Up to $542K
2029-06-30
We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Subscribe for Pro access · Includes AI drafting + templates + PDF export
Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness
NIMH - National Institute of Mental Health — up to $18.3M
COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I
NCI - National Cancer Institute — up to $15.1M
Leveraging Artificial Intelligence to Predict Mental Health Risk among Youth Presenting to Rural Primary Care Clinics
NIMH - National Institute of Mental Health — up to $15.0M
Feasibility of Genomic Newborn Screening Through Public Health Laboratories
OD - NIH Office of the Director — up to $14.4M
WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL COORDINATING CENTER - TASK AREA A AND A2
NHLBI - National Heart Lung and Blood Institute — up to $10.2M
Metal Exposures, Omics, and AD/ADRD risk in Diverse US Adults
NIA - National Institute on Aging — up to $10.2M